Onofrj Valeria, Vallejo Carina, Puac Paulo, Zamora Carlos, Castillo Mauricio
1 Department of Radiology, University of North Carolina Hospitals, USA.
2 Department of Radiology, Clinica Santiago de Leon, Venezuela.
Neuroradiol J. 2018 Dec;31(6):565-571. doi: 10.1177/1971400918791699. Epub 2018 Aug 9.
Although symptoms are expected to improve after the resection of pituitary macroadenomas, tumor resection volume does not always correlate with the patient's symptoms. Our objectives were to assess the pre and postoperative volumes of pituitary macroadenomas before, immediately after surgery and at follow-up, and to explore possible associations and correlations among these changes and symptoms.
We retrospectively reviewed the clinical records and the preoperative and postoperative magnetic resonance imaging studies at 24 hours and at 3, 6 and 9 months follow-up of 146 patients who underwent surgery for pituitary macroadenomas. We measured tumor volumes before and after surgery and compared changes with symptom improvement.
The mean preoperative tumor volume was 24.66 cm (standard deviation 65.18 cm, 95% confidence interval (CI) 14-35.32). The most common symptoms were visual/cranial nerve abnormalities (65%) and headaches (56%). Immediately after surgery, symptoms persisted without significant changes in all patients. A progressive tumor volume decrease was noted during follow-up, and symptoms improved in 78% of patients. Despite no imaging evidence of chiasm or cavernous sinus compression, 32 patients showed no symptom improvement. Patients with symptoms for more than 1 year (mean duration of symptoms 26 months, SD 24.3, 95% CI 22.03-29.97 months) had a higher risk of the persistence of symptoms compared to patients with a mean duration of symptoms of less than 1 year (odds ratio 2.5, 95% CI 2.4-3, P < 0.005).
The duration of symptoms prior of surgery is a more important factor than tumor resection volume alone when considering the long-term outcome of symptoms. Furthermore, lack of symptom improvement in the immediate postoperative period does not necessarily represent an inadequate resection.
尽管垂体大腺瘤切除术后症状有望改善,但肿瘤切除体积并不总是与患者症状相关。我们的目的是评估垂体大腺瘤手术前、术后即刻及随访时的体积,并探讨这些变化与症状之间可能存在的关联和相关性。
我们回顾性分析了146例接受垂体大腺瘤手术患者的临床记录以及术前、术后24小时、3个月、6个月和9个月随访时的磁共振成像研究。我们测量了手术前后的肿瘤体积,并将变化与症状改善情况进行比较。
术前肿瘤平均体积为24.66 cm(标准差65.18 cm,95%置信区间(CI)14 - 35.32)。最常见的症状是视觉/颅神经异常(65%)和头痛(56%)。术后即刻,所有患者症状持续且无显著变化。随访期间肿瘤体积逐渐减小,78%的患者症状改善。尽管没有影像学证据显示视交叉或海绵窦受压,但32例患者症状未改善。症状持续超过1年的患者(症状平均持续时间26个月,标准差24.3,95%CI 22.03 - 29.97个月)与症状平均持续时间少于1年的患者相比,症状持续的风险更高(优势比2.5,95%CI 2.4 - 3,P < 0.005)。
在考虑症状的长期预后时,手术前症状持续时间比单纯肿瘤切除体积更重要。此外,术后即刻症状未改善不一定代表切除不充分。